Long-Term Survival of Recurrent Intrahepatic Cholangiocarcinoma: The Impact and Selection of Repeat Surgery

[1]  Le-hua Shi,et al.  Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: Factors associated with long‐term outcomes , 2017, Surgery.

[2]  E. Hatano,et al.  Is Surgical Resection Justified for Advanced Intrahepatic Cholangiocarcinoma? , 2016, Liver Cancer.

[3]  Seung Duk Lee,et al.  Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After Surgery , 2016, Annals of Surgical Oncology.

[4]  E. Hatano,et al.  Significant Improvement in Outcomes of Patients with Intrahepatic Cholangiocarcinoma after Surgery , 2016, World Journal of Surgery.

[5]  P. Bachellier,et al.  First and Repeat Liver Resection for Primary and Recurrent Intrahepatic Cholangiocarcinoma , 2016 .

[6]  M. Kudo,et al.  Report of the 19th follow‐up survey of primary liver cancer in Japan , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[7]  T. Pawlik,et al.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. , 2014, Journal of hepatology.

[8]  M. Choti,et al.  Recurrence after operative management of intrahepatic cholangiocarcinoma. , 2013, Surgery.

[9]  M. Kuang,et al.  Thermal Ablation Versus Repeated Hepatic Resection for Recurrent Intrahepatic Cholangiocarcinoma , 2013, Annals of Surgical Oncology.

[10]  Guoping Wang,et al.  Long-Term Outcomes of Repeat Hepatic Resection in Patients with Recurrent Hepatocellular Carcinoma and Analysis of Recurrent Types and Their Prognosis: A Single-Center Experience in China , 2012, Annals of Surgical Oncology.

[11]  M. Zeng,et al.  A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  P. Malfertheiner,et al.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer , 2010, Expert review of gastroenterology & hepatology.

[13]  M. Miyazaki,et al.  Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan , 2010, British Journal of Cancer.

[14]  G. Brandi,et al.  Intrahepatic Cholangiocarcinoma: Primary Liver Resection and Aggressive Multimodal Treatment of Recurrence Significantly Prolong Survival , 2010, Annals of surgery.

[15]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[16]  U. Neumann,et al.  Recurrent intrahepatic cholangiocarcinoma: single-center experience using repeated hepatectomy and radiofrequency ablation , 2010, Journal of hepato-biliary-pancreatic sciences.

[17]  M. Makuuchi,et al.  Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma , 2003, Annals of surgery.

[18]  S. Thung,et al.  Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. , 1998, Journal of the American College of Surgeons.

[19]  G. Spolverato,et al.  Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection , 2015, Annals of Surgical Oncology.

[20]  M. Aljiffry,et al.  Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. , 2009, Journal of the American College of Surgeons.